﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>3</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2013</Year>
        <Month>06</Month>
        <DAY>30</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells</ArticleTitle>
    <FirstPage>189</FirstPage>
    <LastPage>195</LastPage>
    <ELocationID EIdType="doi">10.5681/apb.2013.031</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Heidari Majd</LastName>
      </Author>
      <Author>
        <FirstName>Jaleh</FirstName>
        <LastName>Barar</LastName>
      </Author>
      <Author>
        <FirstName>Davoud</FirstName>
        <LastName>Asgari</LastName>
      </Author>
      <Author>
        <FirstName>Hadi</FirstName>
        <LastName>Valizadeh</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Rashidi</LastName>
      </Author>
      <Author>
        <FirstName>Vala</FirstName>
        <LastName>Kafil</LastName>
      </Author>
      <Author>
        <FirstName>Javid</FirstName>
        <LastName>Shahbazi</LastName>
      </Author>
      <Author>
        <FirstName>Yadollah</FirstName>
        <LastName>Omidi</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.5681/apb.2013.031</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2012</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: To achieve simultaneous imaging and therapy potentials, targeted fluoromagnetic nanoparticles were synthesized and examined in human breast cancer MCF-7 cells. Methods: Fe3O4 nanoparticles (NPs) were synthesized through thermal decomposition of Fe(acac)3. Then, magnetic nanoparticles (MNPs) modified by dopamine-poly ethylene glycol (PEG)-NH2; finally, half equivalent fluorescein isothiocyanate (FITC) and half equivalent folic acid were conjugated to one equivalent of it. The presence of Fe3O4-DPA-PEG-FA/FITC in the folate receptor (FR) positive MCF-7 cells was determined via fluorescent microscopy to monitor the cellular interaction of MNPs. Results: FT-IR spectra of final compound confirmed existence of fluorescein on folic acid grafted MNPs. The Fe3O4-DPA-PEG-FA/FITC NPs, which displayed a size rang about 30-35 nm using scanning electron microscopy (SEM) and transmission electron microscopy (TEM), were able to actively recognize the FR-positive MCF-7 cells, but not the FR-negative A549 cells. Conclusion: The uniform nano-sized Fe3O4-DPA-PEG-FA/FITC NPs displayed great potential as theranostics and can be used for targeted imaging of various tumors that overexpress FR.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Magnetic nanoparticles</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Folate receptor</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Breast cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MCF-7 cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Internalization</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>